Search hospitals > Nevada > Reno
Saint Mary's Regional Medical Center
Claim this profileReno, Nevada 89503
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
170 reported clinical trials
3 medical researchers
Summary
Saint Mary's Regional Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Cancer, Breast cancer and other specialties. Saint Mary's Regional Medical Center is involved with conducting 170 clinical trials across 368 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Samuel Chacon, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Uterine Tumors
Expert in T-Lymphoblastic Leukemia/Lymphoma
55 reported clinical trials
111 drugs studied
Samuel Chacon, MDSaint Mary's Regional Medical Center3 years of reported clinical research
Studies Bedwetting
Studies Urinary Incontinence
1 reported clinical trial
2 drugs studied
Clinical Trials running at Saint Mary's Regional Medical Center
Breast Cancer
Bladder Cancer
Skin Cancer
Lung Cancer
Bladder Carcinoma
Breast cancer
Stomach Cancer
Kidney Cancer
Testicular cancer
Esophageal Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Mary's Regional Medical Center?
Saint Mary's Regional Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Cancer, Breast cancer and other specialties. Saint Mary's Regional Medical Center is involved with conducting 170 clinical trials across 368 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Samuel Chacon, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.